Summary of project PR001090

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001090. The data can be accessed directly via it's Project DOI: 10.21228/M8T12F This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR001090
Project DOI:doi: 10.21228/M8T12F
Project Title:Sclerostin antibody increases trabecular bone and bone mechanical properties by increasing osteoblast activity damaged by whole-body irradiation in mice
Project Type:Proteomics and Lipidomics basic research
Project Summary:A mouse model study to test the hypothesis that treatment with anti-sclerostin antibody (Scl-Ab) would attenuate the adverse effects of irradiation by increasing bone volume and decreasing BM adipose tissue (BMAT), resulting in better quality bone.
Institute:Mainehealth
Last Name:Vary
First Name:Calvin
Address:81 Research Drive, Scarborough, ME, USA 04074
Email:varyc@mmc.org
Phone:2073968148
Funding Source:NIH

Summary of all studies in project PR001090

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST001704 Sclerostin antibody increases trabecular bone and bone mechanical properties by increasing osteoblast activity damaged by whole-body irradiation in mice Mus musculus Mainehealth MS* 2021-03-01 1 96 Uploaded data (141.6M)*
  logo